Regulators Want Tough Criteria For COVID-19 Vaccine Efficacy Trials
Standardized Endpoints Needed In Phase III Studies
The International Coalition of Medicines Regulatory Authorities have sketched out the criteria that should be met before candidate coronavirus vaccines can proceed into late-stage trials, and agreed on how to design the studies and who should be included.
